• Events Calendar
Patients Rising Now
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Get Involved
  • Become a Member
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Get Involved
  • Become a Member
  • Donate
Open Enrollment: Beware These Insurance Barriers & PBM Schemes

Open Enrollment: Beware These Insurance Barriers & PBM Schemes

Nov 8, 2019 | Health Insurance, News

Every year, patients struggle to pick the right health insurance during open enrollment. That difficult task is made harder by insurance companies and pharmacy benefit managers. “Formularies, specialty tiers, prior authorization — health insurance might as well...
Read more

Congress Grills Secretive PBM Middlemen, but Misses the Most Important Point

Aug 6, 2019 | News

Pharmacy benefit managers, the secretive drug middlemen that pocket billions of dollars in kickbacks, were grilled this past week at a U.S. Senate Finance Committee hearing on drug prices. Senators asked tough questions about what exactly PBMs do – and why pharmacy...
Read more
This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

Jul 23, 2019 | Drug Costs, News, Pharmacy Benefit Managers

As the year began, patients seeking relief from high out-of-pocket health care costs had reason to be optimistic. A proposed rule introduced by the Department of Health and Human Services would have stopped pharmacy benefit managers and insurance companies from...
Read more

Categories

  • Access
  • Actions
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

340B Access to Care Advocacy Alzheimer's Asthma Biden Administration Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Importation Drug Manufacturing Drug Pricing drug rebate fail first FDA H.R.3 Healthcare Inequities Health Insurance hospital bills HR 3708 hsa ICER Imported Drugs Insurance design Joe Biden Lupus medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Step Therapy Telehealth transparency Value Framework

Recent Posts

  • S2 | E42: The False Promise of Current Drug Pricing Reforms
  • Coverage for Preventive Care Is a High-Value Insurance Design
  • Letter Supporting S.4111 Breslin/A.4668 Peoples-Stokes Prohibiting Non-medical Switching
  • Patients Rising Statement on Pro-Patient Health Insurance Benefit Design
  • S2 | E 41: Chronic Disease + the Next Pandemic with Scott Gottlieb

Sign up for updates


Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2021 Patients Rising Now